# Zhejiang Raybow Pharmaceutical Co., Ltd. – FDA Inspection, Jul 11, 2019

Source: https://www.keypedia.com/records/fda_inspections/zhejiang-raybow-pharmaceutical-co-ltd/e0890c9e-f2cb-4fb8-b257-6c695dc09031
Source feed: FDA_Inspections

> FDA inspection 1096223 of Zhejiang Raybow Pharmaceutical Co., Ltd., July 11, 2019. Classification: Voluntary Action Indicated (VAI). Form 483 issued. 3 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1096223
- Company Name: Zhejiang Raybow Pharmaceutical Co., Ltd.
- Inspection Date: 2019-07-11
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 1256688 - 2024-11-01
- FDA Inspection 976084 - 2016-04-22
- FDA Inspection 878238 - 2014-04-29

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/marcus-a-ray/d394d757-5569-4697-bec1-c24113e29d6f)

Company: https://www.keypedia.com/companies/zhejiang-raybow-pharmaceutical-co-ltd/b4c7f26e-3fb0-4e7a-bc29-aa526cf9ec74

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c